Affordable Access

deepdyve-link
Publisher Website

Natural Occurring Compounds Inhibit Osteoclastogenesis via Targeting NFATc1-related Signaling Pathways.

Authors
  • Wang, Jun1
  • Zheng, Haishi2
  • Ma, Rui3
  • 1 Department of Anesthesiology, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, No.5 Weiyang West Road, Qindu District, Xianyang, Shaanxi, China. , (China)
  • 2 Department of Thoracic Surgery, Beijing Chaoyang Hospital, the Affiliated Hospital of Capital Medical University, No. 8, South Workers Stadium, Beijing, China. , (China)
  • 3 Department of Anesthesiology, Xi'an Children's Hospital, Xi'an, China. , (China)
Type
Published Article
Journal
Current drug targets
Publication Date
Jan 01, 2020
Volume
21
Issue
4
Pages
358–364
Identifiers
DOI: 10.2174/1389450120666191017121610
PMID: 31625474
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Osteoclasts are originated from monocytic precursors of the hematopoietic lineage. Regulation of gene expression by transcription factors is one of the major mechanisms for controlling cellular functions. This is particularly important in the process of osteoclast production. As a main regulatory transcriptional factor, nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) plays a significant role in osteoclast differentiation. Although current studies focus on the regulatory effects of treatment in the process of osteoclastogenesis, many of these drugs possess cytotoxicity which is harmful to bone formation. Naturally occurring compounds with less or no side effects are most required in present clinical and fundamental study. In this paper, we summarize several plant-derived compounds in inhibiting osteoclastogenesis. Copyright© Bentham Science Publishers; For any queries, please email at [email protected]

Report this publication

Statistics

Seen <100 times